‘Regulatory process should have separate pathways for biologics and biosimilars’
Member companies from Biotechnology Industry Organization (BIO) have indicated their reluctance to partner with Indian companies…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Indian pharma growth outpaces rivals: Cambridge Consultants
Workshop reveals innovation and technology as key differentiators
Claris Lifesciences receives ANDA approvals
Ondensetron injection will help in the treatment of nausea and vomiting
Lupin receives US FDA approval
Will help in treatment of otitis media, acute exacerbation of chronic bronchitis
Venus Remedies Meropenem receives market authorisation in Mexico
Plans to launch its first product in the market within the first quarter of fiscal year 2014
Glenmark confirms patent challenge for its generic version of FINACEA
Filed an ANDA for Azelaic Acid, Gel 15 per cent Topical, with US FDA
ABLE celebrates its 10th anniversary
Charts biotech industry’s road map for the next decade by addressing the challenges and concerns. Shalini Gupta reports